MedPath
TGA Approval

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in pre-filled syringe (313681)

313681

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in pre-filled syringe

Novartis Pharmaceuticals Australia Pty Ltd

January 16, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c6b630585415ea0c7c071a41ed5a1aae.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3d979f1621ac96e1327b2387969928db.pdf

Active Ingredients

brolucizumab

© Copyright 2025. All Rights Reserved by MedPath
BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in pre-filled syringe (313681) - TGA 批准文号 | MedPath